Matches in SemOpenAlex for { <https://semopenalex.org/work/W3089315765> ?p ?o ?g. }
- W3089315765 endingPage "605" @default.
- W3089315765 startingPage "597" @default.
- W3089315765 abstract "Mounting evidence supports the occurrence of accelerating aging among long-term survivors of childhood cancer. We aimed to investigate epigenetic age acceleration (EAA) in survivors and evaluate associations between EAA, treatment exposures, health behaviors, and chronic health conditions (CHCs).Genome-wide methylation data were generated with Infinium EPIC BeadChip on blood-derived DNA from 2139 survivors and 282 frequency matched controls from the St Jude Lifetime Cohort Study. EAAs were estimated as residuals from a linear regression of epigenetic age (Levine's clock) against chronological age. Adjusted least square mean (ALSM) of EAA was calculated and compared between survivors and controls, across treatment exposures and health behaviors. Associations of EAA with 20 clinically assessed CHCs were evaluated with multivariable piecewise-exponential models. All statistical tests for P values below were 2-sided.EAA was statistically significantly higher in survivors than controls (ALSM = 0.63, 95% confidence interval [CI] = 0.26 to 1.01 vs -3.61, 95% CI = -4.43 to 2.80). In a multivariable model among survivors, statistically significantly higher EAA (P < .05) was observed in those exposed to chest radiotherapy, abdomen or pelvic radiotherapy, alkylating agents, glucocorticoids, or epipodophyllotoxins. Compared with survivors with favorable health behaviors (ALSM = 0.26, 95% CI=-0.36 to 0.87), EAA was statistically significantly higher among survivors with intermediate (ALSM = 1.07, 95% CI = 0.59 to 1.54) or unfavorable health behaviors (ALSM = 1.45, 95% CI = 0.60 to 2.30). In time-to-event analyses, statistically significant associations were identified between EAA tertiles and incidence of 7 CHCs: hypertension (3rd vs 1st tertile, relative rate [RR] = 1.83, 95% CI = 1.17 to 2.83), myocardial infarction (RR = 2.91, 95% CI = 1.27 to 7.21), obesity (RR = 1.39, 95% CI = 1.17 to 1.66), obstructive pulmonary deficit (RR = 1.86, 95% CI = 0.95 to 3.77), peripheral motor neuropathy (RR = 2.89, 95% CI = 1.24 to 6.97), peripheral sensory neuropathy (RR = 2.04, 95% CI = 0.99 to 4.26), and pulmonary diffusion deficits (RR = 2.75, 95% CI = 0.95 to 7.63).EAA is statistically significantly higher in survivors of childhood cancer than in noncancer controls and is associated with specific treatment exposures, unfavorable health behaviors, and presence of specific CHCs." @default.
- W3089315765 created "2020-10-01" @default.
- W3089315765 creator A5006819204 @default.
- W3089315765 creator A5008672006 @default.
- W3089315765 creator A5024394762 @default.
- W3089315765 creator A5025610733 @default.
- W3089315765 creator A5033767117 @default.
- W3089315765 creator A5037102607 @default.
- W3089315765 creator A5037634832 @default.
- W3089315765 creator A5055144206 @default.
- W3089315765 creator A5055482046 @default.
- W3089315765 creator A5059262359 @default.
- W3089315765 creator A5060877490 @default.
- W3089315765 creator A5064287277 @default.
- W3089315765 creator A5073492643 @default.
- W3089315765 creator A5074963110 @default.
- W3089315765 creator A5076437188 @default.
- W3089315765 creator A5085251424 @default.
- W3089315765 creator A5089743648 @default.
- W3089315765 date "2020-09-24" @default.
- W3089315765 modified "2023-10-01" @default.
- W3089315765 title "Epigenetic Age Acceleration and Chronic Health Conditions Among Adult Survivors of Childhood Cancer" @default.
- W3089315765 cites W1499533057 @default.
- W3089315765 cites W1839076539 @default.
- W3089315765 cites W1917341586 @default.
- W3089315765 cites W1974047233 @default.
- W3089315765 cites W1981015651 @default.
- W3089315765 cites W2008424347 @default.
- W3089315765 cites W2029275609 @default.
- W3089315765 cites W2050202644 @default.
- W3089315765 cites W2050646440 @default.
- W3089315765 cites W2057260087 @default.
- W3089315765 cites W2064968846 @default.
- W3089315765 cites W2076475209 @default.
- W3089315765 cites W2081403346 @default.
- W3089315765 cites W2092761963 @default.
- W3089315765 cites W2094144162 @default.
- W3089315765 cites W2108771604 @default.
- W3089315765 cites W2121091193 @default.
- W3089315765 cites W2121411489 @default.
- W3089315765 cites W2126525177 @default.
- W3089315765 cites W2128937521 @default.
- W3089315765 cites W2163726181 @default.
- W3089315765 cites W2164059021 @default.
- W3089315765 cites W2168889003 @default.
- W3089315765 cites W2290343632 @default.
- W3089315765 cites W2323716083 @default.
- W3089315765 cites W2336855366 @default.
- W3089315765 cites W2519953954 @default.
- W3089315765 cites W2549881333 @default.
- W3089315765 cites W2562655012 @default.
- W3089315765 cites W2567469168 @default.
- W3089315765 cites W2589088833 @default.
- W3089315765 cites W2752414510 @default.
- W3089315765 cites W2796559433 @default.
- W3089315765 cites W2806161996 @default.
- W3089315765 cites W2885738092 @default.
- W3089315765 cites W2900726805 @default.
- W3089315765 cites W2949100461 @default.
- W3089315765 cites W2971106516 @default.
- W3089315765 cites W2993731040 @default.
- W3089315765 cites W3001977817 @default.
- W3089315765 cites W3011046135 @default.
- W3089315765 doi "https://doi.org/10.1093/jnci/djaa147" @default.
- W3089315765 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8096366" @default.
- W3089315765 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32970815" @default.
- W3089315765 hasPublicationYear "2020" @default.
- W3089315765 type Work @default.
- W3089315765 sameAs 3089315765 @default.
- W3089315765 citedByCount "29" @default.
- W3089315765 countsByYear W30893157652021 @default.
- W3089315765 countsByYear W30893157652022 @default.
- W3089315765 countsByYear W30893157652023 @default.
- W3089315765 crossrefType "journal-article" @default.
- W3089315765 hasAuthorship W3089315765A5006819204 @default.
- W3089315765 hasAuthorship W3089315765A5008672006 @default.
- W3089315765 hasAuthorship W3089315765A5024394762 @default.
- W3089315765 hasAuthorship W3089315765A5025610733 @default.
- W3089315765 hasAuthorship W3089315765A5033767117 @default.
- W3089315765 hasAuthorship W3089315765A5037102607 @default.
- W3089315765 hasAuthorship W3089315765A5037634832 @default.
- W3089315765 hasAuthorship W3089315765A5055144206 @default.
- W3089315765 hasAuthorship W3089315765A5055482046 @default.
- W3089315765 hasAuthorship W3089315765A5059262359 @default.
- W3089315765 hasAuthorship W3089315765A5060877490 @default.
- W3089315765 hasAuthorship W3089315765A5064287277 @default.
- W3089315765 hasAuthorship W3089315765A5073492643 @default.
- W3089315765 hasAuthorship W3089315765A5074963110 @default.
- W3089315765 hasAuthorship W3089315765A5076437188 @default.
- W3089315765 hasAuthorship W3089315765A5085251424 @default.
- W3089315765 hasAuthorship W3089315765A5089743648 @default.
- W3089315765 hasBestOaLocation W30893157652 @default.
- W3089315765 hasConcept C121608353 @default.
- W3089315765 hasConcept C126322002 @default.
- W3089315765 hasConcept C144024400 @default.
- W3089315765 hasConcept C149923435 @default.
- W3089315765 hasConcept C2777179973 @default.
- W3089315765 hasConcept C44249647 @default.